| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 橘红系列(元) | - | 87,811,767.13 | 36,843,372.40 | 107,902,762.39 | 109,832,030.12 |
| 抗病毒口服液(元) | - | 139,482,152.71 | 63,995,343.15 | 83,697,335.03 | 101,129,201.11 |
| 中药材(元) | 447,102,905.32 | 978,509,658.09 | 529,877,830.20 | 936,104,066.83 | 445,203,119.57 |
| 分部间抵销(元) | -95,926,442.63 | - | - | - | - |
| 医疗器械(元) | 7,279,291.88 | - | - | - | - |
| 医药流通(元) | 21,111,417.79 | - | - | - | - |
| 医药制造(元) | 186,719,537.59 | - | - | - | - |
| 其他(元) | 136,489,782.16 | 389,603,727.63 | 187,277,276.26 | 730,957,968.17 | 440,378,478.70 |
| 营业成本(元) | |||||
| 橘红系列(元) | - | 49,965,045.07 | 29,347,613.89 | 71,369,688.24 | 45,639,703.80 |
| 抗病毒口服液(元) | - | 134,865,691.39 | 64,111,565.49 | 127,132,466.74 | 77,873,490.68 |
| 中药材(元) | 291,643,235.60 | 678,940,446.69 | 349,373,872.40 | 655,798,089.63 | 309,587,287.07 |
| 分部间抵销(元) | -84,078,231.10 | - | - | - | - |
| 医疗器械(元) | 849,833.86 | - | - | - | - |
| 医药流通(元) | 15,115,638.38 | - | - | - | - |
| 医药制造(元) | 139,240,283.06 | - | - | - | - |
| 其他(元) | 112,443,382.47 | 295,697,089.10 | 141,822,576.62 | 551,506,276.64 | 301,036,915.20 |
| 毛利(元) | |||||
| 橘红系列(元) | - | 37,846,722.06 | 7,495,758.51 | 36,533,074.15 | 64,192,326.32 |
| 抗病毒口服液(元) | - | 4,616,461.32 | -116,222.34 | -43,435,131.71 | 23,255,710.43 |
| 中药材(元) | 155,459,669.72 | 299,569,211.40 | 180,503,957.80 | 280,305,977.20 | 135,615,832.50 |
| 分部间抵销(元) | -11,848,211.53 | - | - | - | - |
| 医疗器械(元) | 6,429,458.02 | - | - | - | - |
| 医药流通(元) | 5,995,779.41 | - | - | - | - |
| 医药制造(元) | 47,479,254.53 | - | - | - | - |
| 其他(元) | 24,046,399.69 | 93,906,638.53 | 45,454,699.64 | 179,451,691.53 | 139,341,563.50 |
| 毛利率(%) | |||||
| 橘红系列(%) | - | 43.10 | 20.34 | 33.86 | 58.45 |
| 抗病毒口服液(%) | - | 3.31 | -0.18 | -51.90 | 23.00 |
| 中药材(%) | 34.77 | 30.61 | 34.07 | 29.94 | 30.46 |
| 分部间抵销(%) | 12.35 | - | - | - | - |
| 医疗器械(%) | 88.33 | - | - | - | - |
| 医药流通(%) | 28.40 | - | - | - | - |
| 医药制造(%) | 25.43 | - | - | - | - |
| 其他(%) | 17.62 | 24.10 | 24.27 | 24.55 | 31.64 |
| 收入构成(%) | |||||
| 橘红系列(%) | - | 5.50 | 4.50 | 5.81 | 10.02 |
| 抗病毒口服液(%) | - | 8.74 | 7.82 | 4.50 | 9.22 |
| 中药材(%) | 63.62 | 61.33 | 64.78 | 50.36 | 40.60 |
| 分部间抵销(%) | -13.65 | - | - | - | - |
| 医疗器械(%) | 1.04 | - | - | - | - |
| 医药流通(%) | 3.00 | - | - | - | - |
| 医药制造(%) | 26.57 | - | - | - | - |
| 其他(%) | 19.42 | 24.42 | 22.89 | 39.33 | 40.16 |
| 毛利构成(%) | |||||
| 橘红系列(%) | - | 8.68 | 3.21 | 8.07 | 17.71 |
| 抗病毒口服液(%) | - | 1.06 | -0.05 | -9.59 | 6.42 |
| 中药材(%) | 68.32 | 68.72 | 77.36 | 61.90 | 37.42 |
| 分部间抵销(%) | -5.21 | - | - | - | - |
| 医疗器械(%) | 2.83 | - | - | - | - |
| 医药流通(%) | 2.63 | - | - | - | - |
| 医药制造(%) | 20.86 | - | - | - | - |
| 其他(%) | 10.57 | 21.54 | 19.48 | 39.63 | 38.45 |